Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are fatal diseases; however, their pathogenesis still remains to be elucidated. We have recently screened novel pathogenic molecules and have performed drug discovery targeting those molecules. Pulmonary...
Main Authors: | Kimio Satoh, Nobuhiro Kikuchi, Taijyu Satoh, Ryo Kurosawa, Shinichiro Sunamura, Mohammad Abdul Hai Siddique, Junichi Omura, Nobuhiro Yaoita, Hiroaki Shimokawa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/19/12/4081 |
Similar Items
-
Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty – A randomized controlled study
by: Tatsuo Aoki, et al.
Published: (2020-08-01) -
Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact
by: Mario Naranjo, et al.
Published: (2021-05-01) -
Novel diagnostic and therapeutic approaches to pulmonary hypertension due to the unilateral absence of a pulmonary artery
by: Yuki Nagamatsu, et al.
Published: (2021-08-01) -
Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
by: Yuichi Tamura, et al.
Published: (2021-01-01) -
Novel Strategies to Reduce Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia
by: Ahmed El-Saie, et al.
Published: (2020-05-01)